There are many benefits to this method. The solution to the optimisation problem is a global minimum, whereas other machine learning methods, such as neural networks, can often terminate in local minima 2 , thereby modelling the training data inaccurately. The SVM solution is an expansion on a subset of the original SVM technique revolves around the notion of a 'margin', either side of a hyperplane that separates two data classes. Maximising the margin, and thereby creating the largest possible distance between the separating hyperplane and the examples on either side of it, is proven to reduce an upper bound on the expected generalisation error. It is easy to show that, when it is possible to linearly separate two classes, an optimum separating hyperplane can be found by minimising the squared norm ofthe separating hyperplane. The minimisation can be formulated as a convex quadratic programming (QP) problem, in which the training data are represented as a matrix of inner products between feature vectors. Once the optimum separating hyperplane is found, data points that lie on its margin are known as support vector points and the solution is an expansion on these points only. Other data points may be ignored ( Figure 1) . trammg data, resulting in a sparser model and less computation time required for subsequent classification. Finally, as mentioned above, an SVM minimises the expected generalisation error, rather than just the empirical error, on the training data. Thus, it can be proven that SVMs should generalise better than many of their counterparts/. A downside is that the quadratic optimisation scales poorly with the number of training examples, as the matrix of inner products grows proportionally to the number of training examples squared. This results in long training times for large training sets. The problem is overcome by employing decomposition methods 3 , which provide the same solution in less time by breaking the optimisation problem down into chunks that are solved sequentially as the algorithm progresses.
In the above we assumed linearly separable training data. This is rarely the case. It is often desirable to allow a certain number of training errors, for example when there are noisy, or outlying, points among the training data. The contradiction between providing an optimum separating hyperplane and a tolerance of training errors is solved by including an extra term in the optimisation process. A balance is sought between minimising the number and magnitude of training errors, and maximising the margin of a hyperplane created without them. The gross magnitude of any training errors made is multiplied by a regularisation constant, 'C'. The constant controls how heavily training errors are penalised and, therefore, how many are allowed in the solution.
Deliberately misclassified points are treated as if they lie on the margin at the correct side of the decision boundary, as shown in Figure 2 .
Should a non-linear decision boundary be required, the hyperplane theory is maintained by the use ofkernel functions. As described above, the
Introduction

Principles of support vector machines
The Support Vector Machine is a supervised machine learning technique, developed by Vapnik and coworkers from his original work on Structural Risk Minimisation /. Instead of minimising error on the training data, the SVM minimises a bound on the expected generalisation error. This is accomplished by minimising a composite error, comprised of the training error plus a regularisation term relating to the complexity of the classifier.
SVMs have been formulated for supervised classification (both binary and multi-class), regression and timeseries estimation. For simplicity, the remainder of this section describes the binary classification scenario. The Machine learning techniques have been used in drug discovery for a number of years. Nevertheless, pharmaceutical manufacturers are constantly seeking to increase predictive accuracy, either through development of existing techniques or through the introduction of new ones. Support Vector Machines (SVMs) are a recent and powerful addition to the family of supervised machine learning techniques and their application to the drug discovery process may be of considerable benefit.
A brief introduction to the SVM technique is followed by an outline of the combinatorial drug design process, in which the refinement of a search through chemical space is paramount to successful discovery of new pharmaceutical products. The requirements placed on machine learning techniques by a specific area of drug discovery are discussed and the article concludes with an example of the SVM at work on pharmaceutical data. Figure 2 : SVM separation oftwo data classes featuring outlier. SVM is an essentially linear technique. To make it non-linear, the training points are mapped non-linearly to a high-dimensional feature space, where linear separation may be possible. A linear separation in feature space corresponds to a non-linear separation in the original input space. The mapping is never explicitly carried out, however, as the data points only appear in the QP and its solution in terms of inner products. Mercer's kernels 4 are a special class of function that allow the inner products to be calculated directly in feature space, without performing the mapping. The optimisation is carried out in feature space and, because separation in the feature space remains linear, the original formulation still holds. Once a hyperplane has been created, the kernel function is used to map new points into the feature space for classification. A great benefit arises from the kernel formulation. The SVM is dimensionally independent, whereas other machine learning techniques, such as neural networks and decision trees, are not. Model complexity of an SVM is unaffected by the number of attributes encountered in the training data. Thus, the 'curse of dimensionality' is avoided.
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It is possible to design specific kernel mappings, incorporating domain knowledge, that separate the training data precisely, but it is easier to use one from a family of kernel functions that represent familiar machine learning techniques. These range from simple linear and polynomial mappings to sigmoids and radial basis functions (RBFs). An RBF kernel maps the training data into an infinite-dimensional space, the expressivity of which is controlled by adjusting the width of the basis functions.
Good parameter selection is crucial
Combinatorial chemistry
The philosophy behind drug discovery has changed radically over the past twenty years. Before the 1980s, the common method was to identify a biological target and to develop, ab initio, a compound to react with it in the desired manner? This method, both laborious and expensive, was superseded by combinatorial chemistry, which involves a search by elimination through chemical space for a 'backbone' compound and a subsequent development of it. Thousands of molecular combinations are tested against the target per day, in a process known as high throughput screening (HTS). Given that there is an enormous number of possible molecular combinations 8 , it is clear that, even at the above-mentioned levels of throughput, it would take years to exhaust all possible solutions to a particular biological problem. The search through chemical space, for compounds with development potential, must therefore be focussed for HTS to be a viable proposition 9 . Machine learning techniques, in various forms, have been regularly employed to narrow the search. The techniques used to the SVM's success, but kernel range from straightforward statistical function settings are difficult to select classification methods, such as nearbefore encountering the training data. est-neighbour and linear discriminant There are several heuristic methods classifiers JO , to more sophisticated for selecting kernel parameters 5 and it methods, such as decision trees ll and is common practise to estimate a neural networks!2. Unsupervised range of potential settings, e.g. sever-learning techniques, such as clusteral orders of polynomial, and to use ing and Kohonen networks, are also cross-validation 6 over the training set used for data visualisation and comto find the best. The same can be done pound selection!2. 13. over a range of 'C' values, to find the 0 The relationship between molecular best level of regularisation. Selecting structure and biological activity has kernel settings and the regularisation been established since the latter half parameter can be regarded in a similar of the 19th century? Methods to way as choosing the number of hidden analyse this relationship have been nodes in a neural network or the prun-developed and expanded over the ing severity of a decision tree. years and are now covered under a The SVM provides a technique with broad range of cheminformatic techa globally optimum solution, simple niques, known as structure-activity implementation, theoretical bounds relationship (SAR) analysis. Models on expected generalisation error, few of chemical space, which relate free parameters, dimensional inde-molecular structure to target attribpendence and a sparse solution. Poor utes, such as toxicity, absorption and scaling with problem size and param-even 'drug-likeness', are used eter selection can often be overcome throughout the drug discovery through the use of decomposition process, in order to classify the suitmethods and heuristic parameter esti-ability of new molecular combinamation. Such difficulties are, in any tions. case, mild in comparison to those
The combinatorial production encountered in the use of neural net-process begins with the identification works.
of a target macromolecule and the reaction required between it and an eventual pharmaceutical product. A good example of this is a cancerous cell and a compound that inhibits its development. The initial form of the search is dictated by what is known about the target. Should little knowledge be available, it is likely that the majority of the corporate compound database will be tested against the target, to find candidates for development. Prior knowledge may be available, however, through rigorous analysis of the target structure, the results of similar previous activities or through naturally occurring substances that produce the desired reaction with the target. Such prior knowledge allows the designers to focus the search. Rather than searching the whole corporate library, an appropriate sub-section may be examined. 
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create a library of 10000 new binary compounds. The contents of a combinatorial library are tested against the target in large in vitro assays (HTS). Compounds that show signs of success against the target during HTS ('hits') become candidates for development during subsequent stages of the production process. The number of hits to emerge from HTS can vary, according to the compounds tested and the reaction sought, from tens to thousands. The majority of those that do make it through, however, will often be unsuitable for further development. Although they react with the target in the required manner, many may be metabolically incompatible, structurally unsuitable or covered under existing patents. Such compounds must be weeded out (lead generation), to leave a set of compounds that are examined in greater detail during subsequent stages of the process. Machine learning techniques are used at this stage to learn relationships between molecular structure and certain criteria that the hits must fulfil, in order to remain in the development process. Once a selection of suitable compounds has been obtained, their properties are optimised for the task in hand (lead optimisation). During lead optimisation, machine learning is used primarily to prioritise the development of certain, especially suitable, compounds. Having narrowed the search from billions of potential molecular combinations to a handful of candidates, 'traditional' laboratory work is intensified. Subsequent trials progress through 'candidate evaluation', 'first time in man' and 'proof of concept'.
Our research focuses on part of the lead generation process. Pharmaceutical companies use generic compound libraries, designed to cover as much chemical space with as few compounds as possible, to train classifiers that are able to select and prioritise the development of hits emerging from HTS. Each library contains a set of compounds (approx. 100-1000) with known structural attributes. At this stage of the process, the target attribute is likely to be binary, i.e. good/poor, toxic/non-toxic, active/inactive. Chemists select the structural attributes used, to give as much relevant structural information about the training compounds as possible. Thus, classification of new compounds is made after examining certain attributes of interest. We shall see in the following section that, even after careful construction of descriptive compound libraries, the problem of describing chemical space from a small subset of existing compounds provides plenty of obstacles for the analyst to overcome.
Structure-activity relationship data
SAR data sets pose a stem test of any technique used to develop relationships from them. Despite the effort that goes into selecting relevant structural attributes, it is rare for the compound classes to be easily separable 14 . In other words, the classes often overlap. In addition to class overlap, mislabelled compounds (noise) may further complicate the modelling process. Compounds are commonly mislabelled in this scenario, as the classes to which they belong are open to interpretation. For example, if we wish to separate the data into active and inactive classes, it is likely that we will threshold a continuous activity attribute in order to do so. Not only is the threshold to be chosen, but the continuum on which it is based may also contain noise. Common sources of noise include procedural variation, such as measurements recorded on different subjects in differing quantities, and analytical variation, such as measurements recorded and analysed in different laboratories by different scientists. Differing compound classification conventions may also complicate matters. Unlike many other industrial machine learning applications, there is little noise within the structural attribute values, as they are calculated deterministically. Nevertheless, if the rules used to calculate the features were developed for compounds not representative of those of interest, then the calculated properties may also be erroneous.
SAR data can be represented in a number of different ways. Compounds are described by both real-valued and binary calculations of selected structural attributes. In binary representations, or structural keys15, bits that are switched on represent the existence of a certain feature or quantity. Abstract representations of molecular structure, fingerprints, are also used to extract underlying relationships between molecular structure and a target activity16. Such represen-tations are usually of high dimension (l024-bit strings are common) and the space that they describe extremely sparse. SAR data commonly contains strong correlations between attributes, which can adversely affect many machine learning techniques14. The question of feature selection is a complicated one. We require a set of relevant structural attributes with which o to describe the region of chemical space under examination. Too few and the region is described in insufficient detail, too many and feature redundancy will hide the significant relationships within the data.
Many training sets contain far more uninteresting points (inactive compounds) than interesting ones (active compounds). This may lead a learning algorithm to focus more strongly on classifying inactive compounds correctly, when we require the opposite. The inherent uncertainty, however small, attached to predictions made according to data that may be incorrect itself or incorrectly modelled, requires careful consideration. The potential ramifications of an incorrect prediction must be taken into account when considering the notion of classifier accuracy. For example, should a potential new drug be rejected early in the search, the loss could be enormous. On the other hand, the longer useless compounds are allowed to remain in the discovery process, the greater the cost of the drug development. It is preferable to allow a small number of poor compounds to remain, rather than misclassify good ones. It must be remembered, however, that the primary aim of modelling in this application is to narrow the search space by elimination. Any technique that allows costs to be placed on potential misclassification of the classes is of special interest to the analyst. There are no concrete benchmarks by which to assess whether, or not, a model is particularly successful. Comparisons are commonly made between different techniques on the same, or similar, data.
Any machine learning technique used to model SAR data must have the following attributes: pounds, 256 of which cross the BBB and 48 or which do not. The SVM will have no contact with the hold-out data until a final set-up has been selected. No assumptions are made about the structure of the hold-out data, i.e. class populations, except that it is drawn from the same area of chemical space as the training data.
The relationships between the attributes and the ability of a compound to cross the BBB are sufficiently complex to warrant the use of an RBF kernel in the SVM. The first parameter choice to be made, therefore, is the width of the RBF kernel. Given that the two classes (positive/negative) are not easily separable, a regularisation parameter must also be chosen. The parameters are chosen as follows. The training set is split into five, stratified, cross-validation folds. The SVM is trained and tested on each fold in turn and the results averaged to give an estimated generalisation error. Each training/test split contains the same proportion of class populations as the training data. Five heuristic methods of choosing the RBF width and three values of 'C' {I, I 0, I OO} are tested. This results in 15 cross-validation trials (each comprising 5 training and test runs) to chose the SVM parameters.
To place the SVM's performance into perspective, four more machine learning techniques were evaluated alongside it. The techniques selected
Results
2-1ayer
Nel>M>lk
1-1ayer
Nel>M>lk
As can be seen in Figure 3 , the SVM records slightly higher overall accuracy (76%) than the other techniques (71 %-73%) on the hold-out set. More importantly, when the accuracy on each class is examined, it retains more of the compounds that cross the BBB, i.e. the ones we wish to keep in the development process, than the other techniques. The breakdown of class specific accuracy is shown in Table 1 , below. Table 1 shows that, in this trial, the SVM correctly predicts 12 positive compounds more than its nearest rival (two-layer neural net), at the expense of not rejecting 3 negative compounds more. It should be noted that the test set class proportions were highly were the C5.0 decision tree and onelayer, two-layer and RBF neural networks, implemented on the Clementine machine learning toolbox. The SVM itself was implemented using the mathematical programming language, Matlab. The decision tree and neural networks were optimised in a similar manner to the SVM, with five-fold stratified cross-validation ,used to estimate the performance of several network architectures and levels of tree pruning severity. The results of the optimised SVM, tree and networks are displayed in Figure  3 , below. 
Example -crossing the blood I brain barrier
GlaxoSmithKline Pharmaceuticals have provided an example, on which we have examined the SVM's performance. The aim of the example is to classify whether a compound will cross the bloodlbrain barrier (BBB). Those that cross the BBB warrant further attention. Those that don't are eliminated from the discovery process. The training data consists of 172 compounds, 81 of which cross the BBB and 91 ofwhich do not. All compounds are described by 72, real-valued structural attributes. A separate, hold-out, data set is used to evaluate the generalisation ability of the relationship learned on the training data. This hold-out set contains 304 com-o High overall generalisation accuracy.
Factors of lesser importance to this application than to some other areas of the drug discovery process include training time and interpretability of results. Compared to training time, the time taken to predict the properties of unknown compounds is more important in this scenario. As mentioned in the first section, an SVM does not scale well with the number of training examples that it faces. It does classify new points quickly, however, as its solution is an expansion on a subset of the training data. Here we train on relatively few compounds, but use the relationship learned to classify many more. When narrowing the compound search to generate leads, classification accuracy is more important than the amount of information delivered about the classifications made. Further downstream, in lead optimisation for example, more information may be required, to aid in the development of lead compounds.
On the basis of the above criteria, the SVM should prove particularly applicable to this area of industrial classification.
Technique
Overall Accuracy (0/0) Positive Compound Negative Compound Accuracy (0/0) Accuracy (0/0)
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unbalanced compared to the training set, although, as no assumptions were made as to its nature, this could not be taken into account during training.
Conclusions
The Support Vector Machine has been introduced and shown to be well suited to a familiar machine learning application in pharmaceutical drug discovery. The theoretical advantages that the SVM brings to machine learning in drug discovery have been outlined and a specific area of the discovery process (SAR analysis) discussed. In a trial on data provided by GlaxoSmithKline Pharmaceuticals, the SVM outperformed four frequently used techniques, showing especially high accuracy in classifYing the more important of two compound classes. Future work on this subject will examine methods of improving SVM performance on the negative class without affecting its high accuracy on the positive class.
